RxDoctor Payments Data

Alejandro Rivas Campo, MD

Otology & Neurotology · Cleveland, OHNPI 1174662977

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (50.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Grace Medical, Inc. at 53.1% of the total. 2025 is the largest year on record at $15,306, 3.6 times the $4,241 reported in 2019.

$43,331in general payments, 2019–2025

Across 85 payments — averaging $509.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Grace Medical, Inc.$23K
  • Cochlear Americas$18K
  • Stryker$541
  • Advanced Bionics, LLC$389
  • Oticon Medical, LLC$187
  • Baxter Healthcare$138
  • plus $553 from 6 others
$1,549,960in research payments, 2019–2025

Across 124 payments — averaging $12,500 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$1.4M
  • Advanced Bionics, LLC$173K
  • Cook Research Incorporated$15K

What the payments were for

  • Royalty or licence$22,04251%
  • Consulting fees$11,69227%
  • Travel & lodging$5,30712%
  • Food & beverage$4,29110%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$77,416
Medicare patients
173
Services billed
501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth45$6,335
Ofloxacin32$982
Azelastine Hcl18$452
Fluticasone Propionate19$184
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid24$143
Prednisone21$85

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →